Abstract: A lens module including a base, a lens, a front cover, at least a shielding plate and a gasket is provided. The lens is disposed on the base. The front cover is disposed above the base and the lens, and the base and the front cover may rotate relatively. The shielding plate is pivoted on the base and has a first guide portion. The gasket is fixed on the front cover, the shielding plate is located between the gasket and the base. The gasket has a through hole corresponding to the lens and a second guide portion coupled to the first guide portion. When the base and the front cover rotate relatively, the first guide portion is guided by the second guide portion, the shielding plate can limitedly swing to move to the through hole to cover the lens or move away from the through hole to expose the lens.

Abstract: A method for obtaining care information, a method for sharing care information, and an electronic apparatus therefor are provided. The method for obtaining care information includes following steps: obtaining face data of a current user from an image capturing equipment and obtaining initial skin information of the face data. classifying the current user into one of a plurality of groups according to the initial skin information by a cloud database; setting a predetermined time period and a skin-condition goal by the electronic apparatus; and obtaining a skin-achievement history of an another user in the group containing the current user according to the initial skin information, the predetermined time period and the skin-condition goal by the electronic apparatus. The skin-achievement history is care information regarding the skin-condition goal achieved by the another user under circumstances of the approximate initial skin information and the approximate predetermined time period.

Abstract: Methods, systems, and devices are disclosed herein for conducting skin analysis for a user.

Abstract: The present invention relates to therapeutic agents comprising bispecific recombinant antibody fragments to selectively clear a protein associated with a neurological disease and methods of use of these therapeutic agents to treat neurological diseases.

Abstract: The present invention relates to therapeutic agents comprising bispecific recombinant antibody fragments to selectively clear a protein associated with a neurological disease and methods of use of these therapeutic agents to treat neurological diseases.

Abstract: Compositions that inhibit or block the interaction between Erbin and ErbB2 and methods of their use are provided. Preferred compositions include peptides that inhibit or block Erbin and ErbB2 interaction under physiologic conditions in a subject. One embodiment provides an isolated peptide fragment of ErbB2 including the C-terminal 15 amino acids of ErbB2. The peptide fragment can be about 15 to 27 amino acids in length.

Abstract: Systems, devices, and methods, including executable instructions and/or logic thereon, are provided for server site selection. A system includes a load balancing master configured to have a domain name server (DNS) capability with extensions to support iterative control and a manager capability to select among server sites to probe. The system includes a load balancing slave, communicatively coupled to the master, configured to have a DNS reflection capability to measure a round trip time (RTT) between the load balancing slave and a client local DNS server and an actor capability to respond to commands from the manager and to report a measured RTT to the load balancing master.

Abstract: A base station subsystem (1000), a TMA part (100) and a RBS part (150) of a communication system employing TDD; and respective methods are provided for synchronizing the RBS part of the base station subsystem (1000) with the TMA part (100) The RBS part (150) comprises an RBS modem (160) adapted to generate a switch signal comprising a switch command word, and to further send the switch signal to a TMA modem (110). The TMA modem (110) is adapted to demodulate the switch signal and to compare the switch command word with switch command words stored in a register. When any of the switch command words in the register (111) matches the switch command word of the demodulated switch signal, the TMA modem (110) is configured to generate a control signal for controlling a switch of the TMA part for synchronizing the RBS part (150) with the TMA part.

Abstract: A system and method for generating shape graphs for a routing table are described herein. The method includes splitting a binary trie representing a routing table of a router into a number of layers, wherein each layer includes a number of nodes. The method also includes, for each layer, determining a number of groups of isomorphic nodes and merging the isomorphic nodes within each group to generate a shape graph.

Abstract: A wafer clamp according to one embodiment includes an outer ring, and at least three members extending inwardly from the outer ring, each of the members having a contact area for engaging a wafer. A system includes a structure having at least one ring, each ring being for receiving a wafer, and a wafer clamp configured to clamp a wafer to each ring, the wafer clamp having an outer ring, and at least three members extending inwardly from the outer ring, each of the members having a contact area for engaging a wafer.

Abstract: A magnetic head including a magnetoresistive junction and an oxide layer. The magnetoresistive junction includes a pinned layer, a free layer, and a barrier layer residing between the pinned and free layer. The magnetoresistive junction includes at least one side having a smooth profile. The oxide layer is on the at least one side. The oxide layer is less than one nanometer thick at the free layer.

Abstract: Systems, devices, and methods, including executable instructions and/or logic thereon, are provided for server site selection. A system includes a load balancing master configured to have a domain name server (DNS) capability with extensions to support iterative control and a manager capability to select among server sites to probe. The system includes a load balancing slave, communicatively coupled to the master, configured to have a DNS reflection capability to measure a round trip time (RTT) between the load balancing slave and a client local DNS server and an actor capability to respond to commands from the manager and to report a measured RTT to the load balancing master.

Abstract: Systems (360), methods (240), and machine-readable and executable instructions (368) are provided for selecting a server. Server selection can include receiving a first query (114 and 242) at a management server (106) from a local server (104). Server selection can also include triggering a reply race (116, 244) by sending a number of query notifications from the management server (106) to a number of actor servers (108-1, 108-2, and 108-3), wherein each of the number of actor servers (108-1, 108-2, and 108-3), in response to receiving the query notifications (116), sends a response (118) to the local server (104) and wherein a first actor server (108-1) from the number of actor servers (108-1, 108-2, and 108-3) is selected (120) by the local server (104). Server selection can further include resolving, at the management server (116), future queries (246) from the local server by referencing a first report that was received (126) from the first actor server.

Abstract: The present invention relates to therapeutic agents comprising bispecific recombinant antibody fragments to selectively clear a protein associated with a neurological disease and methods of use of these therapeutic agents to treat neurological diseases.

Abstract: The present invention relates to the application of 5-methyl-1,3-benzenediol or its derivatives represented by Formula I; wherein the constituent variables are as defined herein or pharmaceutical compositions thereof containing them in the preparation of medicines or functional foods. The present studies indicate that 5-methyl-1,3-benzenediol or its derivatives represented by Formula I, wherein the constituent variables are as defined herein or pharmaceutical compositions thereof containing them show more significant antidepressant effects than fluoxetine or imipramine.

Abstract: An integrated design-for-manufacturing (DFM) platform is provided. The integrated DFM platform an automatic warning and verification system; an automatic data feedback and feed forward system; an automatic intellectual property (IP) library management system; and a data management system integrated under a same platform.

Abstract: A method for providing a magnetic transducer including an underlayer is provided. The method comprises providing a recessed region in the underlayer. The recessed region includes a front having an angle from horizontal. The angle is greater than zero and less than ninety degrees. The method further comprises providing an assist pole layer in the recessed region, providing a main pole layer, a portion of the main pole layer residing on the assist pole layer, and defining a main pole from the assist pole layer and the main pole layer.

Abstract: Compositions that inhibit or block the interaction between Erbin and ErbB2 and methods of their use are provided. Preferred compositions include peptides that inhibit or block Erbin and ErbB2 interaction under physiologic conditions in a subject. One embodiment provides an isolated peptide fragment of ErbB2 including the C-terminal 15 amino acids of ErbB2. The peptide fragment can be about 15 to 27 amino acids in length.

Abstract: A method provides a PMR transducer. In one aspect, the method includes forming a trench in an intermediate layer using reactive ion etch(es). The trench top is wider than its bottom. In this aspect, the method also includes providing a seed layer using atomic layer deposition and providing a PMR pole on the seed layer. Portion(s) of the seed layer and PMR pole reside in the trench. In another aspect, the method includes providing a mask including a trench having a top wider than its bottom. In this aspect, the method includes providing mask material in the trench, providing an intermediate layer on the mask material and removing the mask material to provide another trench in the intermediate layer. In this aspect, the method also includes providing a PMR pole in the additional trench.